Literature DB >> 20602365

Modification of luminescent iridium(III) polypyridine complexes with discrete poly(ethylene glycol) (PEG) pendants: synthesis, emissive behavior, intracellular uptake, and PEGylation properties.

Steve Po-Yam Li1, Hua-Wei Liu, Kenneth Yin Zhang, Kenneth Kam-Wing Lo.   

Abstract

We report the synthesis, characterization, and photophysical properties of a new class of luminescent cyclometalated iridium(III) polypyridine poly(ethylene glycol) (PEG) complexes [Ir(N--C)(2)(N--N)](PF(6)) (HN--C=Hppy (2-phenylpyridine), N--N=bpy-CONH-PEG1 (bpy=2,2'-bipyridine; 1a), bpy-CONH-PEG3 (1b); HN--C=Hpq (2-phenylquinoline), N--N=bpy-CONH-PEG1 (2a), bpy-CONH-PEG3 (2b); HN--C=Hpba (4-(2-pyridyl)benzaldehyde), N--N=bpy-CONH-PEG1 (3)) and their PEG-free counterparts (N--N=bpy-CONH-Et, HN--C=Hppy (1c); HN--C=Hpq (2c)). The cytotoxicity and cellular uptake of these complexes have been investigated by the MTT assay, ICPMS, laser-scanning confocal microscopy, and flow cytometry. The results showed that the complexes supported by the water-soluble PEG can act as biological probes and labels with considerably reduced cytotoxicity. Because the aldehyde groups of complex 3 are reactive toward primary amines, the complex has been utilized as the first luminescent PEGylation reagent. Bovine serum albumin (BSA) and poly(ethyleneimine) (PEI) have been PEGylated with this complex, and the resulting conjugates have been isolated, purified, and their photophysical properties studied. The DNA-binding and gene-delivery properties of the luminescent PEI conjugate 3-PEI have also been investigated.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20602365     DOI: 10.1002/chem.201000474

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  6 in total

Review 1.  Metal Peptide Conjugates in Cell and Tissue Imaging and Biosensing.

Authors:  Karmel S Gkika; David Cullinane; Tia E Keyes
Journal:  Top Curr Chem (Cham)       Date:  2022-06-15

2.  Mitochondria-targeted spin-labelled luminescent iridium anticancer complexes.

Authors:  V Venkatesh; Raul Berrocal-Martin; Christopher J Wedge; Isolda Romero-Canelón; Carlos Sanchez-Cano; Ji-Inn Song; James P C Coverdale; Pingyu Zhang; Guy J Clarkson; Abraha Habtemariam; Steven W Magennis; Robert J Deeth; Peter J Sadler
Journal:  Chem Sci       Date:  2017-10-20       Impact factor: 9.825

3.  Phosphorescent cationic iridium(iii) complexes dynamically bound to cyclodextrin vesicles: applications in live cell imaging.

Authors:  Frauke Schibilla; Anna Holthenrich; Boyi Song; Anna Lívia Linard Matos; David Grill; Diego Rota Martir; Volker Gerke; Eli Zysman-Colman; Bart Jan Ravoo
Journal:  Chem Sci       Date:  2018-08-09       Impact factor: 9.825

Review 4.  Water-Soluble Tris(cyclometalated) Iridium(III) Complexes for Aqueous Electron and Energy Transfer Photochemistry.

Authors:  Mirjam R Schreier; Xingwei Guo; Björn Pfund; Yasunori Okamoto; Thomas R Ward; Christoph Kerzig; Oliver S Wenger
Journal:  Acc Chem Res       Date:  2022-04-12       Impact factor: 24.466

5.  Biocompatible Ir(III) Complexes as Oxygen Sensors for Phosphorescence Lifetime Imaging.

Authors:  Ilya S Kritchenkov; Anastasia I Solomatina; Daria O Kozina; Vitaly V Porsev; Victor V Sokolov; Marina V Shirmanova; Maria M Lukina; Anastasia D Komarova; Vladislav I Shcheslavskiy; Tatiana N Belyaeva; Ilia K Litvinov; Anna V Salova; Elena S Kornilova; Daniel V Kachkin; Sergey P Tunik
Journal:  Molecules       Date:  2021-05-13       Impact factor: 4.411

6.  Luminescent Bimetallic IrIII /AuI Peptide Bioconjugates as Potential Theranostic Agents.

Authors:  Andrés Luengo; Isabel Marzo; Matthew Reback; Isabelle M Daubit; Vanesa Fernández-Moreira; Nils Metzler-Nolte; M Concepción Gimeno
Journal:  Chemistry       Date:  2020-09-02       Impact factor: 5.236

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.